$125M Deal Awaits OK In Bristol-Myers Class Action

Law360, New York (November 23, 2009, 1:14 PM EST) -- The lead plaintiff in a securities class action claiming Bristol-Myers Squibb Co. hid the terms of a deal it struck with a generics maker over the patent for its blood-thinning drug Plavix has asked a judge to give the final seal of approval to a $125 million settlement with the drugmaker.

Lead plaintiff the Ontario Teachers' Pension Plan Board moved for final approval of the deal on Friday in the U.S. District Court for the Southern District of New York, noting that not a single party...
To view the full article, register now.